Ratings Kiwoom Securities Co., Ltd.

Equities

A039490

KR7039490008

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-05-30 pm EDT			5-day change	1st Jan Change
133,800 ^KRW	+0.75%		+6.70%	+34.47%

May. 20	UTI Inc. announced that it expects to receive KRW 25.849114068 billion in funding from a group of investors	CI
May. 16	Chabiotech Co.,Ltd. announced that it has received KRW 74.799682128 billion in funding from a group of investors	CI

Strengths

Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
Its low valuation, with P/E ratio at 4.75 and 4.54 for the ongoing fiscal year and 2025 respectively, makes the stock pretty attractive with regard to earnings multiples.
The company appears to be poorly valued given its net asset value.
Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.
For the last 4 months, the company has been enjoying highly positive EPS revisions, which were frequently and significantly raised.
Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
Analyst opinion has improved significantly over the past four months.

Ratings chart - Surperformance

Sector: Investment Banking & Brokerage Services

	1st Jan change	Capi.	ESG Refinitiv
KIWOOM SECURITIES CO., LTD.	+34.47%	2.61B	-
MORGAN STANLEY	+4.92%	159B	C-
THE GOLDMAN SACHS GROUP, INC.	+18.34%	155B	C+
CHARLES SCHWAB	+6.51%	134B	B-
CITIGROUP INC.	+21.13%	119B	C+
CITIC SECURITIES COMPANY LIMITED	-8.59%	35.44B	B+
RAYMOND JAMES FINANCIAL, INC.	+10.10%	25.44B	B
LPL FINANCIAL HOLDINGS INC.	+25.74%	21.38B	B+
CSC FINANCIAL CO., LTD.	-9.42%	19.99B	B+
NOMURA HOLDINGS, INC.	+49.05%	18.02B	B

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes